CellVoyant leverages AI and live-cell imaging to predict cellular behavior, transforming cell therapy development and making ...

In the program’s first year, it has reduced delays for radiation treatment by 40 per cent and surgery volumes have more than ...

Absci Corporation stock has dropped since January, driven by weak earnings and broader biotech sector pressures. Learn more ...

PE-backed specialty pharma company Kelso Pharma appointed Giovanni Mauri as general manager of its recently acquired Italian ...

It is time to showcase the names and faces of the future who are set to shape and define the technology sector in 2025, and ...

Alliance University, Karnataka's first private university established in 2010 and recognized by the University Gra ...

AI systems already work their magic in many areas of biomedical science, helping to solve protein structure, discover hidden ...

Beam Therapeutics Inc.’s BEAM share price has surged by 5.12%, which has investors questioning if this is right time to sell.

Discover how genetic diversity in India is being studied through the GenomeIndia project, impacting disease research and ...

In addition to these internal advantages, external investors and other stakeholders are also increasingly considering ...

Semarion's SemaCyte® technology transforms adherent cell assays, enabling faster, automated workflows that enhance ...

The companies that sell synthesized DNA to scientists need to screen their customers, lest dangerous sequences for pathogens ...